Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients

Nephrology Dialysis Transplantation

Volumn 21, Issue 9, 2006, Pages 2621-2624

  Boudville, Neil C ^a,b   Hodsman, Anthony B ^c,d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

25 hydroxyvitamin D; Cholecalciferol; Hyperparathyroidism; Renal transplant; Transplantation; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; CALCIUM; CREATININE; ERGOCALCIFEROL; PARATHYROID HORMONE; PHOSPHATE; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; DRUG DERIVATIVE; VITAMIN D;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DISEASE EXACERBATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MULTIPLE LINEAR REGRESSION ANALYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PREDICTION; PREVALENCE; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; UNIVARIATE ANALYSIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RADIOIMMUNOASSAY; RETROSPECTIVE STUDY;

BIOLOGICAL MARKERS; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PARATHYROID HORMONE; PROGNOSIS; RADIOIMMUNOASSAY; RETROSPECTIVE STUDIES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 33750106236     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl201     Document Type: Article

References (19)

1. Eastwood JB, Stamp TCB, De Wardener HE, Bordier PJ, Anraud CD. The effect of 25-hydroxy vitamin D3 in the osteomalacia of chronic renal failure. Clin Sci Mol Med 1977; 52: 499-508
2. Birge SJ, Haddad JG. 25-hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest 1975; 56: 1100-1107
3. Visser M, Deeg DJH, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The longitudinal ageing study Amsterdam. J Clin Endocrinol Metab 2003; 88: 5766-5772
4. Krause R, Bühring M, Hopfenmüller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet 1998; 352: 709-710
5. Flicker L, Mead K, MacInnis RJ et al. Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 2003; 51: 1533-1538
6. Ghazali A, Fardellone P, Pruna A et al. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Losser. Kidney Int 1999; 55: 2169-2177
7. Fournier A, Fardellone P, Archard JM et al. Importance of vitamin D repletion in uremia. Nephrol Dial Transplant 1999; 14: 819-823
8. Ooms ME, Roos JC, Bezemer PD, Van Der Vijgh WJF, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: A randomized double-blind trial. J Clin Endocrinol Metab 1995; 80: 1052-1058
9. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842-856
10. Cannata-Andía JB, Alonso CG. Vitamin D deficiency: A neglected aspect of disturbed calcium metabolism in renal failure. Nephrol Dial Transplant 2002; 17: 1875-1878
11. Gómez-Alonso C, Naves-Díaz ML, Fernández-Martín JL, Díaz-López JB, Fernández-Coto MT, Cannata-Andía JB. Vitamin D status and secondary hyperparathyroidism: The importance of 25-hydroxyvitamin D cut-off levels. Kidney Int 2003; 63: S44-S48
12. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42 [4 Suppl 3]: S1-S201
13. Dumoulin G, Hory B, Nguyen NU et al. No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients. Am J Kidney Dis 1997; 29: 746-753
14. Torres A, Rodriguez AP, Concepcion MT et al. Parathyroid function in long-term renal transplant patients: Importance of pre-transplant PTH concentrations. Nephrol Dial Transplant 1998; 13: 94-97
15. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991; 325: 544-550
16. Reinhardt W, Bartelworth H, Jockenhovel F et al. Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant 1998; 13: 436-442
17. Lomonte C, Antonelli M, Vernaglione L et al. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients? J Nephrol 2005; 18: 96-101
18. Lamb EJ, Tomson CRV, Roderick PJ. Estimating kidney function in adults using formulae. Ann Clin Biochem 2005; 42: 321-345
19. Rucker D, Allan JA, Fick GH, Hanley DA. Vitamin D insufficiency in a population of healthy western Canadians. CMAJ 2002; 166: 1517-1524